547 related articles for article (PubMed ID: 26674797)
41. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
[TBL] [Abstract][Full Text] [Related]
42. Phospholipase A2 Receptor Autoantibodies as a Novel Serological Biomarker for Autoimmune Thyroid Disease Associated Nephropathy.
Huang B; Zhang Y; Wang L; Wu Q; Li T; Zhang J; Zhang Q; Sheng H; Bao J; Hu Z
Front Immunol; 2020; 11():837. PubMed ID: 32425952
[No Abstract] [Full Text] [Related]
43. Establishment and application of an immunoassay for the simultaneous detection of IgG and its subtype IgG4 autoantibodies against M-type phospholipase A2 receptor.
Li T; Wu Q; Yang X; Zhang Y; Zhou X; Sheng H; Wang Y; Zhang Q; Liu X; Qin Y; Huang B; Wang L; He Q; Hu Z
Clin Biochem; 2021 Oct; 96():49-55. PubMed ID: 34252448
[TBL] [Abstract][Full Text] [Related]
44. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.
Oh YJ; Yang SH; Kim DK; Kang SW; Kim YS
PLoS One; 2013; 8(4):e62151. PubMed ID: 23637987
[TBL] [Abstract][Full Text] [Related]
45. Clinical and pathological features of idiopathic membranous nephropathy in young people.
Lin C; Zheng D; Wang Y; Wang S
Nephrology (Carlton); 2019 Jun; 24(6):599-604. PubMed ID: 30175519
[TBL] [Abstract][Full Text] [Related]
46. Serum anti-phospholipase A2 receptor antibody in pathological diagnosis of type 2 diabetes mellitus patients with proteinuria.
Zhang H; Zhu Y; Hu Z; Liu Q
Sci Rep; 2023 Oct; 13(1):16608. PubMed ID: 37789020
[TBL] [Abstract][Full Text] [Related]
47. Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy.
Li C; Li H; Wen YB; Li XM; Li XW
BMC Nephrol; 2018 Dec; 19(1):354. PubMed ID: 30541581
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.
Pourcine F; Dahan K; Mihout F; Cachanado M; Brocheriou I; Debiec H; Ronco P
PLoS One; 2017; 12(3):e0173201. PubMed ID: 28257452
[TBL] [Abstract][Full Text] [Related]
49. A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor.
Zhang Q; Liu X; Zhang Z; Wu M; Huang B; Zhang Y; Liu B; Qi Z; Shan W; Wang L; Hu Z; Sun Z
Medicine (Baltimore); 2019 Nov; 98(45):e17658. PubMed ID: 31702617
[TBL] [Abstract][Full Text] [Related]
50. Comparison of 3 anti-PLA2R inmmunoassaysfor the diagnosis of idiopathic membranous nephropathy in an european population. A pilot study.
Nieto-Gañán I; Rita CG; Villacorta-Pérez J; Ortego-Pérez S; Rodríguez-Mendiola N; Carrasco-Sayalero Á
Clin Immunol; 2021 Jun; 227():108729. PubMed ID: 33872763
[TBL] [Abstract][Full Text] [Related]
51. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.
Xiao C; Liu Y; Zhang X; Luo L; Li X; Wang T; Tian Z; Qin X; Liu J
J Clin Lab Anal; 2020 Sep; 34(9):e23368. PubMed ID: 32449206
[TBL] [Abstract][Full Text] [Related]
52. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
[TBL] [Abstract][Full Text] [Related]
53. M-type phospholipase A
Kanda S; Horita S; Yanagihara T; Shimizu A; Hattori M
Pediatr Nephrol; 2017 Apr; 32(4):713-717. PubMed ID: 27921164
[TBL] [Abstract][Full Text] [Related]
54. Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis.
Dong D; Fan TT; Wang YY; Zhang L; Song L; Zhang L
BMC Nephrol; 2019 Dec; 20(1):444. PubMed ID: 31791262
[TBL] [Abstract][Full Text] [Related]
55. Anti-PLA2R and anti-THSD7A as Diagnostic Serological Markers of Idiopathic Membranous Nephropathy: A Single Centre Study.
Fouad MA; Mahedy AW; Mansour AE; Fouad NA
Egypt J Immunol; 2020 Jun; 27(2):1-9. PubMed ID: 33548972
[TBL] [Abstract][Full Text] [Related]
56. Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.
Bech AP; Hofstra JM; Brenchley PE; Wetzels JF
Clin J Am Soc Nephrol; 2014 Aug; 9(8):1386-92. PubMed ID: 25035272
[TBL] [Abstract][Full Text] [Related]
57. Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy.
Wei SY; Wang YX; Li JS; Zhao SL; Diao TT; Wang Y; Wang C; Qin Y; Cao Y; Wei Q; Li B
Am J Nephrol; 2016; 43(2):129-40. PubMed ID: 27058841
[TBL] [Abstract][Full Text] [Related]
58. Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.
Burbelo PD; Joshi M; Chaturvedi A; Little DJ; Thurlow JS; Waldman M; Olson SW
J Am Soc Nephrol; 2020 Jan; 31(1):208-217. PubMed ID: 31843984
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis.
Hu SL; Wang D; Gou WJ; Lei QF; Ma TA; Cheng JZ
J Nephrol; 2014 Apr; 27(2):111-6. PubMed ID: 24500886
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy.
Akiyama S; Akiyama M; Imai E; Ozaki T; Matsuo S; Maruyama S
Clin Exp Nephrol; 2015 Aug; 19(4):653-60. PubMed ID: 25412738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
